Eski Yaja
Vice President of Investor Relations
Replay available
Inspire Medical Systems, Inc. (NYSE: INSP) Q4 2025 earnings conference call, held 2026-02-11. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations
Chairman and Chief Executive Officer
Chief Financial Officer
Analyst, Piper Sandler
Analyst, CIFL
Analyst, JPMorgan
Analyst, Bank of America Securities
Analyst, Baird
Watch the replay and follow the connected company analysis, news, and investor updates for Inspire Medical Systems, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.018 Good afternoon. My name is Dilem, and I'll be your conference operator today. 00:00:05.018 -- 00:00:09.184 At this time, I'd like to welcome everyone to the Inspire Medical Systems fourth quarter 00:00:09.184 -- 00:00:14.231 and full year 2025 conference call. All lines have been placed on mute to prevent 00:00:14.231 -- 00:00:19.178 any background noise. After the speaker's remarks, there will be a question and answer 00:00:19.178 -- 00:00:24.466 session. I'll now hand the call over to your first speaker, Eski Yaja, the Vice President 00:00:24.466 -- 00:00:29.089 of Investor Relations at Inspire. You may begin the conference. 00:00:29.258 -- 00:00:33.524 Thank you, Dilem, and thank you all for participating in today's call. 00:00:33.524 -- 00:00:38.750 Joining me are Tim Herbert, Chairman and Chief Executive Officer, and Matt Osberg, Chief 00:00:38.750 -- 00:00:43.957 Financial Officer. Earlier today, we released financial results for the three 00:00:43.957 -- 00:00:47.879 and 12 months ended December 31st, 2025. 00:00:48.142 -- 00:00:52.368 A copy of the press release is available on our website. 00:00:52.368 -- 00:00:56.533 On this call, management will make forward-looking statements within the meaning of the 00:00:56.533 -- 00:01:01.978 federal securities laws. all forward-looking statements, including, without limitation, 00:01:01.978 -- 00:01:07.167 those relating to our operations, financial results and financial condition, 00:01:07.167 -- 00:01:12.918 investments in our business, full-year 2026 financial and operational outlook, 00:01:12.918 -- 00:01:18.067 and changes in market access and different aspects of coding or reimbursement are based 00:01:18.067 -- 00:01:21.250 upon our current estimates and various assumptions....